Evidence map›Paper›PMID 21714498›Full record

ArticleBiochemistry2011

Molecular basis for an ancient partnership between prolyl isomerase Pin1 and phosphatase inhibitor-2.

Furqan Sami, Caroline Smet-Nocca, Meera Khan, Isabelle Landrieu, Guy Lippens, David L Brautigan

Abstract readComparative Study
In one paragraph

Article in Biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Furqan SamiCenter for Cell Signaling and Department of Microbiology, University of Virginia School of Medicine, Box 800577-MSB7225, Charlottesville, Virginia 22908, United States.
Caroline Smet-Nocca
Meera Khan
Isabelle Landrieu
Guy Lippens
David L Brautigan
Unité de Glycobiologie Structurale et Fonctionnelle · FRUniversity of Virginia · USCentre National de la Recherche Scientifique · FR

Funding

Phosphorylation & Function of Inhibitor-2R01GM056362 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BRAUTIGAN, DAVID L. · 1997 to 2011
$2.4M
NIGMS NIH HHS GM56362NIGMS NIH HHS R01 GM056362
6 · The paper itself

Abstract

Pin1 is a prolyl isomerase that recognizes phosphorylated Ser/Thr-Pro sites, and phosphatase inhibitor-2 (I-2) is phosphorylated during mitosis at a PSpTP site that is expected to be a Pin1 substrate. However, we previously discovered I-2, but not phospho-I-2, bound to Pin1 as an allosteric modifier of Pin1 substrate specificity [Li, M., et al. (2008) Biochemistry 47, 292]. Here, we use binding assays and NMR spectroscopy to map the interactions on Pin1 and I-2 to elucidate the organization of this complex. Despite having sequences that are ∼50% identical, human, Xenopus, and Drosophila I-2 proteins all exhibited identical, saturable binding to GST-Pin1 with K(0.5) values of 0.3 μM. The (1)H-(15)N heteronuclear single-quantum coherence spectra for both the WW domain and isomerase domain of Pin1 showed distinctive shifts upon addition of I-2. Conversely, as shown by NMR spectroscopy, specific regions of I-2 were affected by addition of Pin1. A single-residue I68A substitution in I-2 weakened binding to Pin1 by half and essentially eliminated binding to the isolated WW domain. On the other hand, truncation of I-2 to residue 152 had a minimal effect on binding to the WW domain but eliminated binding to the isomerase domain. Size exclusion chromatography revealed that wild-type I-2 and Pin1 formed a large (>300 kDa) complex and I-2(I68A) formed a complex of half the size that we propose are a heterotetramer and a heterodimer, respectively. Pin1 and I-2 are conserved among eukaryotes from yeast to humans, and we propose they make up an ancient partnership that provides a means for regulating Pin1 specificity and function.

Indexed as

Sequence Homology, Amino AcidAllosteric RegulationAmino Acid SequenceAnimalsConserved SequenceDrosophila ProteinsEscherichia coli ProteinsHumansMolecular Sequence DataNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomerasePhosphoprotein PhosphatasesPhosphorylationProtein BindingProtein MultimerizationProtein Phosphatase Inhibitory Proteinsdod protein, DrosophilaDrosophila ProteinsEscherichia coli ProteinsESS1 protein, S cerevisiaeNIMA-Interacting Peptidylprolyl IsomeraseparvA protein, E coliPeptidylprolyl IsomerasePhosphoprotein PhosphatasesPIN1 protein, humanPin1 protein, Xenopusprotein phosphatase inhibitor-2Protein Phosphatase Inhibitory ProteinsProteinsSaccharomyces cerevisiae ProteinsXenopus Proteins

Identifiers

PMID21714498
PMCPMC3965691
OpenAlexW2034476906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.